archive-au.com » AU » C » CSL.COM.AU

Total: 502

Choose link from "Titles, links and description words view":

Or switch to "Titles and links view".
  • Search Results
    Address AGM Oct13 CSL Limited Chairman s Address Annual General Meeting 2013 I am very pleased to report that CSL has recorded another year of strong performance with continuing growth across http www csl com au airmans 20Address 20AGM 20Oct13 pdf 4D CSL Limited ABN 99 051 588 348 ASX Half year Information 31 December 2009 Lodged with Contents Page Results for Announcement to the Market 1 Half year Report 2 CSL Limited ABN http www csl com au c 202009 20v7 20 ASX 20release pdf Microsoft Word 1H12 ASX release FINAL docx CSL Limited ABN 99 051 588 348 ASX Half year Information 31 December 2011 Lodged with Contents Page Results for Announcement to the Market 1 Half year Report 2 1 CSL Limited http www csl com au L HY 2012 Financial Information pdf 4D CSL Limited ABN 99 051 588 348 ASX Half year Information 31 December 2012 Lodged with Contents Page Results for Announcement to the Market 1 Half year Report 3 1 CSL Limited http www csl com au 20 2031 20Dec 202012 20 FINAL pdf Microsoft Word CSL Half year ASX reporting App 4D 31 Dec CSL Limited ABN 99 051 588 348 ASX Half year Information 31 December 2010 Lodged with Contents Page Results for Announcement to the Market 1 Half year Report 2 1 CSL Limited http www csl com au p 204D 31Dec2010 20 ASX Release pdf 4D CSL Limited ABN 99 051 588 348 ASX Half year Information 31 December 2007 Lodged with Contents Page Results for Announcement to the Market 1 Half year Report 2 CSL Limited ABN http www csl com au 04D 20 2031 20Dec 202007 20v7 pdf untitled CSL LIMITED SHAREHOLDER REVIEW 2008 2009 CSL Limited ABN 99 051 588 348 Shareholder Review 2008 2009 FINANCIAL

    Original URL path: http://www.csl.com.au/s1/cs/auhq/1255924054987/page/1255924054283/SearchResults.htm?query=csl&pr=CSLsites&prox=page&rorder=500&rprox=500&rdfreq=500&rwfreq=500&rlead=500&rdepth=0&sufs=0&order=r&cq=2&jump=40&dropXSL=yes (2014-01-05)
    Open archived version from archive


  • Search Results
    press releases and corporate communications Global Home CSL Behring Global bioCSL All CSL Websites CSL Include All CSL Behring Country Sites Choose country Austria Belgium Luxembourg Brazil Canada China Denmark France http www csl com au newsroom Press Latest Release http www csl com au CSL News Thu 05 Dec 2013 00 00 00 0500 CSL signs agreement with Janssen to progress novel cancer therapy CSL Limited has today announced an agreement http www csl com au s cat 1145993773124 p 1187378853299 CSL Limited Half Year Report 2011 2012 CSL Limited Half Year Report 2011 2012 Dividend to Shareholders An interim unfranked PRofessoR JoHn sHine Ao ChAirmAn half Year Financial results CsL GRouP ResuLts half year http www csl com au docs 181 687 CSL HYR12 sec pdf AARLEG 20847138 v7 CSL Ltd Constitution DOC Constitution of CSL Limited ACN 051 588 348 Corporations Act Company limited by shares Victoria 3052 Australia Constitution of CSL Limited cbpm A0120847138v7 Page i Table http www csl com au 20 20ASX 20Lodgement 20Version pdf Month 00 0000 CSL Limited 2012 Full Year Result 22 August 2012 Disclaimer Forward looking statements The include forward looking statements about CSL Limited and its related bodies corporate http www csl com au docs 635 79 Analyst Presentation pdf CSL Limited 2009 Full Year Result CSL Limited 2010 Full Year Result 18 August 2010 2 Disclaimer Forward looking statements the control of and are unknown to CSL You can identify these forward looking http www csl com au 0 results presentation FINAL NN pdf Microsoft Word Chairman s Address Speech and MD slides Page 1 CSL Limited Chairman s Address Annual General Meeting Wednesday 17 October achieved a US 1 billion profit result CSL has maintained a strong balance sheet with http www csl com au 127 2012

    Original URL path: http://www.csl.com.au/s1/cs/auhq/1255924054987/page/1255924054283/SearchResults.htm?query=csl&pr=CSLsites&prox=page&rorder=500&rprox=500&rdfreq=500&rwfreq=500&rlead=500&rdepth=0&sufs=0&order=r&cq=2&jump=50&dropXSL=yes (2014-01-05)
    Open archived version from archive

  • Search Results
    YEAR REPORT 2012 2013 Professor John shine Ao CSL LIMITED HALF YEAR REPORT 2012 2013 Professor John shine Ao Chairman Half Year financial results CSL Group reSuLtS in us Dollars Six months ended December US millions sales http www csl com au docs 292 186 CSL HYR13 pdf Slide 1 CSL Limited 2011 Full Year Result 17 August 2011 Disclaimer Forward looking statements The the control of and are unknown to CSL You can identify these forward looking http www csl com au 0FY11 20Analysts 20Presentation pdf CSL LIMITED HALF YEAR REPORT CSL LIMITED HALF YEAR REPORT 2010 2011 Dividend to Shareholders An interim unfranked dividend of 35 cents per share is payable on 8 April 2011 CSL Group Results Chairman s Report http www csl com au docs 546 430 CSL HYR11 pdf Slide 1 CSL Limited 2011 12 Half Year Result 22 February 2012 Disclaimer Forward looking the control of and are unknown to CSL You can identify these forward looking http www csl com au L HY 2012 Analysts Presentation pdf Microsoft PowerPoint 1H10 results presentation FINAL NN 2 CSL Limited 2009 10 Half Year Result 17 February 2010 2 Disclaimer Forward looking the control of and are unknown to CSL You can identify these forward looking http www csl com au lts 20presentation 20FINAL 20NN pdf Microsoft PowerPoint 1H11 results presentation FINAL NN Compatib CSL Limited 2010 11 Half Year Result 16 February 2011 2 Disclaimer Forward looking the control of and are unknown to CSL You can identify these forward looking http www csl com au 82 56 1H11 results pres FINALNN pdf News Archive Global Home CSL Behring Global bioCSL All CSL Websites CSL Include All CSL Behring Country Sites Choose country Austria Belgium Luxembourg Brazil Canada China Denmark France http www csl com

    Original URL path: http://www.csl.com.au/s1/cs/auhq/1255924054987/page/1255924054283/SearchResults.htm?query=csl&pr=CSLsites&prox=page&rorder=500&rprox=500&rdfreq=500&rwfreq=500&rlead=500&rdepth=0&sufs=0&order=r&cq=2&jump=60&dropXSL=yes (2014-01-05)
    Open archived version from archive

  • Search Results
    csl com au AGM Chairmans Address abridged pdf Marketing Statement Global Home CSL Behring Global bioCSL All CSL Websites CSL Include All CSL Behring Country Sites Choose country Austria Belgium Luxembourg Brazil Canada China Denmark France http www csl com au 3 content 1196562762133 content htm Microsoft PowerPoint FY09 results presentation FINAL NN ppt CSL Limited 2009 Full Year Result 19 August 2009 2 Disclaimer Forward looking statements the control of and are unknown to CSL You can identify these statements by the http www csl com au lts 20presentation 20FINAL 20NN pdf PowerPoint Presentation CSL Limited 2006 07 Half Year Result 21 February 2007 2 Disclaimer Forward looking the control of and are unknown to CSL You can identify these statements by the http www csl com au docs 19 83 Presentation21Feb2007 pdf Microsoft PowerPoint FY2007 results presentation V8 ppt CSL Limited 2007 Full Year Result 22 August 2007 2 Disclaimer Forward looking statements the control of and are unknown to CSL You can identify these statements by the http www csl com au 2 389 FY2007resultspresentation pdf PowerPoint Presentation CSL Limited 2007 08 Half Year Result 20 February 2008 2 Disclaimer Forward looking the control of and are unknown to CSL You can identify these statements by the http www csl com au esentation 20FINAL 20NO 20NOTES pdf Microsoft PowerPoint FY2008 results presentation FINAL NN with CSL Limited 2008 Full Year Result 13 August 2008 2 Disclaimer Forward looking statements the control of and are unknown to CSL You can identify these statements by the http www csl com au 0presentation 20FINAL 20NN 20v2 pdf CSL Limited CSL Limited 2013年7月 目次 責任ある事業活動の ための行動規程 1 2 7 2 問題の提起 29 用語集 30 目次 CSL Limited ABN 99 051 588 348 http www csl com au 5 CSL CRBP13i JPN001

    Original URL path: http://www.csl.com.au/s1/cs/auhq/1255924054987/page/1255924054283/SearchResults.htm?query=csl&pr=CSLsites&prox=page&rorder=500&rprox=500&rdfreq=500&rwfreq=500&rlead=500&rdepth=0&sufs=0&order=r&cq=2&jump=70&dropXSL=yes (2014-01-05)
    Open archived version from archive

  • Search Results
    900 million of CSL shares Speaking at CSL s annual general meeting in http www csl com au L 20announces 20share 20buyback pdf Highlights for CSL s Research and Development Global Home CSL Behring Global bioCSL All CSL Websites CSL Include All CSL Behring Country Sites Choose country Austria Belgium Luxembourg Brazil Canada China Denmark France http www csl com au h development recent highlights htm News Archive Global Home CSL Behring Global bioCSL All CSL Websites CSL Include All CSL Behring Country Sites Choose country Austria Belgium Luxembourg Brazil Canada China Denmark France http www csl com au 55929883418 PressReleaseArchive htm Archived ASX Releases 2008 2012 Global Home CSL Behring Global bioCSL All CSL Websites CSL Include All CSL Behring Country Sites Choose country Austria Belgium Luxembourg Brazil Canada China Denmark France http www csl com au 55923307862 PressReleaseArchive htm All CSL Websites Global Home CSL Behring Global bioCSL All CSL Websites CSL Include All CSL Behring Country Sites Choose country Austria Belgium Luxembourg Brazil Canada China Denmark France http www csl com au csl websites CSL Limited Privacy Policy Global Home CSL Behring Global bioCSL All CSL Websites CSL Include All CSL Behring Country Sites Choose country Austria Belgium Luxembourg Brazil Canada China Denmark France http www csl com au privacy Terms of Use Global Home CSL Behring Global bioCSL All CSL Websites CSL Include All CSL Behring Country Sites Choose country Austria Belgium Luxembourg Brazil Canada China Denmark France http www csl com au terms of use CSL Ltd is a leader in plasma protein biotherapeutics Global Home CSL Behring Global bioCSL All CSL Websites CSL Include All CSL Behring Country Sites Choose country Austria Belgium Luxembourg Brazil Canada China Denmark France http www csl com au about history 1980 1999 htm CSL Ltd is a leader

    Original URL path: http://www.csl.com.au/s1/cs/auhq/1255924054987/page/1255924054283/SearchResults.htm?query=csl&pr=CSLsites&prox=page&rorder=500&rprox=500&rdfreq=500&rwfreq=500&rlead=500&rdepth=0&sufs=0&order=r&cq=2&jump=80&dropXSL=yes (2014-01-05)
    Open archived version from archive

  • Search Results
    Brazil Canada China Denmark France http www csl com au 091 news 1255929042869 prdetail htm CSL Limited s Board and Management Group Global Home CSL Behring Global bioCSL All CSL Websites CSL Include All CSL Behring Country Sites Choose country Austria Belgium Luxembourg Brazil Canada China Denmark France http www csl com au about board management htm CSL Limited s Global Leadership Group Global Home CSL Behring Global bioCSL All CSL Websites CSL Include All CSL Behring Country Sites Choose country Austria Belgium Luxembourg Brazil Canada China Denmark France http www csl com au agement global leadership group htm In the Marketplace Global Home CSL Behring Global bioCSL All CSL Websites CSL Include All CSL Behring Country Sites Choose country Austria Belgium Luxembourg Brazil Canada China Denmark France http www csl com au rate responsibility marketplace htm CSL Biotherapies provides update on Fluvax investigation Global Home CSL Behring Global bioCSL All CSL Websites CSL Include All CSL Behring Country Sites Choose country Austria Belgium Luxembourg Brazil Canada China Denmark France http www csl com au 299 news 1255929042869 prdetail htm CSL Ltd is a leader in plasma protein biotherapeutics Global Home CSL Behring Global bioCSL All CSL Websites CSL Include All CSL Behring Country Sites Choose country Austria Belgium Luxembourg Brazil Canada China Denmark France http www csl com au about history 1940 1959 htm CSL Announces Changes to the Board Global Home CSL Behring Global bioCSL All CSL Websites CSL Include All CSL Behring Country Sites Choose country Austria Belgium Luxembourg Brazil Canada China Denmark France http www csl com au 231 news 1255927066426 prdetail htm Successor to CEO Brian McNamee Announced Global Home CSL Behring Global bioCSL All CSL Websites CSL Include All CSL Behring Country Sites Choose country Austria Belgium Luxembourg Brazil Canada China Denmark France http

    Original URL path: http://www.csl.com.au/s1/cs/auhq/1255924054987/page/1255924054283/SearchResults.htm?query=csl&pr=CSLsites&prox=page&rorder=500&rprox=500&rdfreq=500&rwfreq=500&rlead=500&rdepth=0&sufs=0&order=r&cq=2&jump=90&dropXSL=yes (2014-01-05)
    Open archived version from archive

  • CSL Ltd is a leader in plasma protein biotherapeutics
    produce sera and vaccine products 1915 Plan to Establish Federal Serum Institute Announced Experience during World War I makes it clear that Australia cannot afford to rely on overseas supplies of important sera and vaccines The country was effectively cut off from its traditional sources of vaccines and other bacteriological products for the duration of the war The decision to establish a federal serum institute CSL is announced on 21 October 1915 1916 CSL Established The Commonwealth Serum Laboratories CSL are established to supply Australia with vaccines and other bacteriological products Dr William Penfold a bacteriologist at Britain s Lister Institute of Preventative Medicine is appointed as CSL s founding Director 1917 Temporary Location The Walter and Eliza Hall Institute of Medical Research WEHI provides CSL with free accommodation in its building in Lonsdale Street Melbourne until a permanent home can be found Collaboration between the two organisations continues to this day 1918 CSL Moved to Permanent Site CSL transfers operations from its temporary base at WEHI to its permanent site in Parkville Melbourne In 1918 Melbourne and Sydney s ports have been placed under quarantine in an attempt to avoid the introduction into Australia of the Spanish Influenza epidemic

    Original URL path: http://www.csl.com.au/about/history/1900-1919.htm (2014-01-05)
    Open archived version from archive

  • CSL Ltd is a leader in plasma protein biotherapeutics
    sera 24 vaccines 4 tuberculins and a range of diagnostic agents Late in 1920 diphtheria toxin antitoxin is introduced to combat one of the most dreaded infectious diseases of the time 1922 Veterinary Vaccines CSL begins producing veterinary vaccines for the first time heralding the introduction of a wide range of veterinary products 1923 Commencement of Insulin Production at CSL In 1922 Canadians Frederick Banting and Charles Best isolated insulin and began a new era in the treatment of diabetes Within months of their discovery CSL produced an experimental batch and in 1923 CSL is one of only four laboratories in the world licensed to manufacture insulin By August CSL is producing enough insulin to meet the needs of all Australian diabetics Left 1924 Insulin Advertisment 1925 Therapeutic Sera Sera are prepared from the blood of people who have recovered from diseases such as poliomyelitis measles and scarlet fever The sera are used both to prevent and treat disease This pioneering work paves the way for the production of large quantities of pooled human serum used for transfusions during World War II 1930 CSL Releases its First Antivenom Tiger snake antivenom is released after several years of collaboration between CSL and the Walter and Eliza Hall Institute CSL will go on to produce antivenoms against all of the dangerous Australian snakes and spiders Staff members at work in their laboratory early 1930 s 1935 CSL Research Section Established An independent research section is established under the leadership of Dr EV Keogh The need for CSL to undertake its own research had been apparent since the earliest days and Dr Keogh in particular had long campaigned for an in house research capability 1938 1939 World War II Initiatives The threat of war means CSL has to prepare itself to meet the

    Original URL path: http://www.csl.com.au/about/history/1920-1939.htm (2014-01-05)
    Open archived version from archive